Free Trial
David Windley

David Windley Analyst Performance

Managing Director at Jefferies Financial Group

David Windley is a stock analyst at Jefferies Financial Group focused in the medical sector, covering 25 publicly traded companies. Over the past year, David Windley has issued 9 stock ratings, including buy and hold recommendations. While full access to David Windley's proprietary MarketBeat Analyst Rating is reserved for MarketBeat All Access subscribers, the rating is updated daily to reflect the most recent analyst activity. This profile highlights David Windley's coverage history, rating activity, and performance tendencies — helping individual investors make more informed trading decisions.

Analyst Ratings, Coverage, and Performance Statistics

Average Return
00.00% 12-Month ROI
Success Rate
00.00% Profitable Ratings
Total Ratings
79 Last 11 Years
Buy Recommendations
67.09% 53 Buy Ratings
Companies Covered
25 Unique Companies

Ratings Distribution

RatingPercentageCount
Strong Buy0.0%0 ratings
Buy67.1%53 ratings
Hold31.6%25 ratings
Sell1.3%1 ratings

Out of 79 total stock ratings issued by David Windley at Jefferies Financial Group, the majority (67.1%) have been Buy recommendations, followed by 31.6% Hold and 1.3% Sell.

Exchange Coverage

ExchangePercentageCount
NYSE
64.0% of companies on NYSE
16 companies
NASDAQ
36.0% of companies on NASDAQ
9 companies

David Windley, an analyst at Jefferies Financial Group, currently covers 25 companies listed on NYSE and NASDAQ, with the majority traded on NYSE.

Coverage Focus

Sector IconSectorPercentage
Medical
20 companies
80.0%
Miscellaneous
2 companies
8.0%
Finance
1 company
4.0%
Business Services
1 company
4.0%
Computer and Technology
1 company
4.0%

David Windley of Jefferies Financial Group specializes in stock coverage within the Medical sector, with additional focus on and Finance companies.

Coverage Industries

IndustryPercentage
MED - HMO
5 companies
20.0%
MEDICAL SERVICES
4 companies
16.0%
MED INSTRUMENTS
2 companies
8.0%
HOSPITAL & MEDICAL SERVICE PLANS
2 companies
8.0%
MED - BIOMED/GENE
1 company
4.0%
INS - MULTI LINE
1 company
4.0%
DIAGNOSTICS & RESEARCH
1 company
4.0%
COMMERCIAL PHYSICAL RESEARCH
1 company
4.0%
COMPUTER INTEGRATED SYSTEMS DESIGN
1 company
4.0%
HEALTH INFORMATION SERVICES
1 company
4.0%
COMMUNICATION EQUIPMENT
1 company
4.0%
BUSINESS SERVICES
1 company
4.0%
PHARMACEUTICAL PREPARATIONS
1 company
4.0%
PREPACKAGED SOFTWARE
1 company
4.0%
Miscellaneous
1 company
4.0%
HOLDING & OTHER INVESTMENT OFFICES
1 company
4.0%

David Windley's Ratings History at Jefferies Financial Group

Recommendation ROI is the percentage between the price on the Report Date to the price 12 months after the report date.
Available with a MarketBeat All Access Subscription
12-Month ROIUpgrade to All Access to use the All ROI Filter
CompanyReport DateActionReport Date Price12-Month
Price Target
Rating12-Month
Price & ROI
Details
Charles River Laboratories International, Inc. stock logo
CRL
Charles River Laboratories International
9/9/2025Upgrade$161.97$195.00Buy
IQVIA Holdings Inc. stock logo
IQV
IQVIA
9/9/2025Upgrade$187.72$225.00Buy
Icon Plc stock logo
ICLR
Icon
9/9/2025Downgrade$177.81$175.00Hold
Medpace Holdings, Inc. stock logo
MEDP
Medpace
9/9/2025Boost Price Target$492.09$450.00Hold
Fortrea Holdings Inc. stock logo
FTRE
Fortrea
9/9/2025Boost Price Target$10.32$9.50Hold
STERIS plc stock logo
STE
STERIS
5/29/2025Initiated Coverage$245.03$263.00Hold
SelectQuote, Inc. stock logo
SLQT
SelectQuote
5/21/2025Initiated Coverage$2.26$2.75Hold
Centene Corporation stock logo
CNC
Centene
4/29/2025Lower Price Target$59.23$61.00Hold
Centene Corporation stock logo
CNC
Centene
4/8/2025Upgrade$61.27$64.00Hold